현장 진단(POC) 검사 시장(제13판)

Now in its thirteenth edition ? Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.

Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry. As healthcare systems continue to shift toward faster, decentralized, and patient-centered care models, point-of-care testing has moved beyond a niche role to become an essential component of clinical decision-making and disease management.

This edition reflects a market that has fundamentally evolved following the COVID-19 pandemic. POC testing is now widely accepted across providers, payers, and patients as a critical extension of laboratory services, enabling rapid results in hospitals, emergency departments, physician offices, pharmacies, and increasingly in the home. The report examines how this structural shift?combined with staffing shortages, pressure to reduce laboratory turnaround times, and demand for near-patient diagnostics?is driving sustained investment and innovation across the sector.

Growth in the POC market is being fueled by several converging forces: the rising global burden of chronic and infectious diseases, aging populations, expanding access to healthcare in emerging markets, and strong patient preference for convenient, rapid testing. At the same time, advances in miniaturization, microfluidics, biosensors, and cartridge-based molecular platforms are significantly expanding the range and complexity of tests that can be performed outside the central laboratory. Molecular point-of-care testing, in particular, is one of the fastest-growing areas, enabling highly sensitive detection of respiratory infections, sexually transmitted infections, healthcare-associated pathogens, and antimicrobial resistance markers in decentralized settings.

The report also highlights the increasing importance of connectivity and digital integration in POC diagnostics. Newer systems are delivering quantitative, lab-quality results with seamless integration into electronic health records, laboratory information systems, and remote care platforms. Artificial intelligence, clinical decision support tools, and cloud-based data management are expected to play a growing role as diagnostic data becomes more integrated into broader care pathways. These capabilities are becoming critical differentiators for manufacturers, as healthcare providers demand solutions that combine analytical performance with workflow efficiency and regulatory compliance.

Another defining trend covered in this edition is the rapid expansion of home testing and pharmacy-based diagnostics. Building on pandemic-era adoption, consumer-directed testing is gaining traction across infectious disease, sexual health, and chronic disease monitoring. This shift is pushing manufacturers to design simpler, connected, and clinically actionable tests that are supported by digital tools, telehealth integration, and clear patient guidance. The convergence of POC testing and remote patient monitoring is also creating new opportunities in areas such as diabetes, cardiovascular disease, and anticoagulation management.

The study provides in-depth segmentation across key diagnostic categories?including glucose and diabetes monitoring, cardiac markers, infectious disease testing, blood gases and electrolytes, coagulation, urinalysis, pregnancy and fertility, cancer markers, and other specialty tests?offering detailed market sizing, growth projections, and competitive analysis. Each segment is evaluated in the context of evolving care delivery models, technological innovation, and reimbursement dynamics.

Enhanced Segmentation

The report delivers detailed analysis across all major POC testing categories, including:

• Blood and Electrolytes
• Cancer Tumor Markers
• Cardiac Markers
• Coagulation
• Colon Cancer
• Drugs of Abuse
• Fecal Occult Blood
• Glucose (including CGM and HbA1c)
• Infectious Disease (including COVID-19, HIV, Hepatitis, STIs, respiratory testing, and OTC/self-testing)
• Lipid
• Pregnancy and Fertility
• Urine
• Other Testing (including microbiology, TSH, allergy, autoimmune, and specialty assays)

Each category includes market sizing, competitive positioning, and five-year forecasts 2025-2030.

Scope and Methodology

The report provides global coverage, with analysis spanning the United States, Europe, Japan, and emerging markets, along with regional demand drivers and healthcare system dynamics. It evaluates the impact of regulatory frameworks?including CLIA waiver pathways and international approval processes?as well as reimbursement trends and evidence requirements shaping adoption.

Market estimates are presented at the manufacturer level, with 2025 as the base year and forecasts through 2030. The analysis incorporates primary and secondary research, including interviews with industry stakeholders, and assesses growth drivers such as decentralization of care, expansion of molecular POC testing, connectivity requirements, and the transition toward value-based healthcare.

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY

• ABOUT KALORAMA INFORMATION
• INTRODUCTION
• SCOPE AND METHODOLOGY
• SIZE AND GROWTH OF THE MARKET
  • Table 1-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
  • Figure 1-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
• TRENDS AFFECTING THE MARKET
• COMPETITIVE OUTLOOK
• CONCLUSIONS
  • Conclusion One: Tariffs Affecting the POC Market
  • Conclusion Two: Rapid Molecular POC Tests Growing
  • Conclusion Three: Multiplex Expansion Beyond COVID and Flu
  • Conclusion Four: Reimbursement Issues Still Loom
  • Conclusion Five: PAMA Affects POC Adoption
  • Conclusion Six: China’s Volume-Based Procurement Putting Pressure on POC Companies

CHAPTER 2: INTRODUCTION AND OVERVIEW

• SCOPE
• POINT-OF-CARE DIAGNOSTICS TESTING
• INDUSTRY REGULATIONS
• TYPES OF CLIA CERTIFICATES
• POC INDUSTRY DRIVERS
  • Patient-focused drivers
  • Medical/Healthcare-related drivers
  • Technology drivers
  • Economic drivers
  • Other drivers
• POC INDUSTRY CHALLENGES
• POC TEST TYPES
  • Blood
  • Urine
  • Saliva
  • Hair
  • Optical Technologies
  • Breath
• CONDITIONS EVALUATED BY POC DIAGNOSTIC TESTING
  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cardiovascular Disease
  • Diabetes
  • Drug Abuse
  • Infectious Disease
  • Herpes
  • HTLV
  • Respiratory Syncytial Virus
  • Hepatitis
  • Lyme Disease
  • Babesiosis
  • Gonorrhea, Syphilis and Chlamydia
  • Trichomonas Vaginalis
  • HIV/AIDS
  • Helicobacter Pylori
  • Influenza
  • Coronavirus
  • Mononucleosis
  • Streptococcus
  • Osteoporosis
  • Pregnancy and Fertility

CHAPTER 3: POC BLOOD GLUCOSE TESTS

• INTRODUCTION AND SCOPE
• TYPES OF BLOOD GLUCOSE TESTING
  • Fasting Blood Sugar (FBS)
  • 2-Hour Postprandial Blood Sugar (PPBS)
  • Random Blood Sugar
  • Glucose Tolerance Test
  • Glucose Urine Test
  • Glycated Hemoglobin (HbA1c)
• PRODUCTS
  • Blood Glucose Self-Testing
    • Table 3-1: Selected Glucose Self-Test Meter Innovations
    • Table 3-2: Selected Apps and Glucose Management IT
  • Continuous Self-Testing
  • Glycated Hemoglobin Tests
    • Table 3-3: Selected POC HbA1c Testing Systems and Related Products
  • Professional
• MARKET SIZE AND GROWTH
  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 3-1: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Table 3-5: Global POC Diabetes Sales, by Test Category, 2025-2030 ($ million) [Glucose, Continuous; Glucose, Professional; Glucose, Self-test; HbA1c, POC]
• Regional Analysis
  • Figure 3-2: POC Blood Glucose Testing Regional Market Analysis, 2025 (%)
• POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices), 2025-2030 (US$ millions, manufacturer level)
• POC Continuous Glucose Self-Testing
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market, 2025-2030 (US$ millions, manufacturer level)
• POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2025-2030 (US$ millions, manufacturer level)
• POC HbA1c Testing
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c), Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 3-3: Global POC Glucose Test Manufacturers, Market Share of Leading Suppliers, 2025 (%)

CHAPTER 4: POC BLOOD AND ELECTROLYTES TESTING MARKET

• INTRODUCTION AND SCOPE
• TYPES OF BLOOD AND ELECTROLYTES TESTS
  • Hemoglobin/Hematocrit
  • WBC and Other
  • Blood Gases
  • Electrolytes
• PRODUCTS
  • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2025
  • Table 4-2: Selected POC Hematology Analyzer Systems, 2025
• MARKET SIZE AND GROWTH
  • Table 4-3: Global POC Blood and Electrolytes Testing Market* Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 4-1: Global POC Blood and Electrolytes Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Table 4-4: Global POC Blood & Electrolytes Revenues, by Test Category, 2025-2030 (US$ millions)
• Regional Analysis
  • Figure 4-2: POC Blood and Electrolytes Testing Regional Market Analysis, 2025 (%)
• POC Blood and Electrolyte Self-Testing
  • Table 4-5: Global POC Blood and Electrolyte Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Blood and Electrolyte Professional Testing
  • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 4-3: Global POC Blood and Electrolyte Testing Market Manufacturers, Market Share of Leading Suppliers, 2025 (%)

CHAPTER 5: POC RAPID COAGULATION

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Table 5-1: Selected POC Coagulation Test Innovations
• Platelet Testing
  • Table 5-2: Selected Platelet Activity Test Innovations
• MARKET SIZE AND GROWTH
  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 5-1: Global Rapid Coagulation Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 5-2: POC Rapid Coagulation Testing Regional Market Analysis, 2025 (%)
• POC Rapid Coagulation Self-Testing
  • Table 5-4: POC Rapid Coagulation Self-Testing, Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 5-3: Global POC Rapid Coagulation Testing Market, Market Share of Leading Suppliers, 2025 (%)

CHAPTER 6: POC RAPID CARDIAC MARKERS

• INTRODUCTION AND SCOPE
• PRODUCTS
• MARKET SIZE AND GROWTH
  • Table 6-1: Total Rapid Total Rapid Cardiac Marker Test Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 6-1: Total POC Rapid Cardiac Marker Test Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 6-2: POC Rapid Cardiac Markers Testing Regional Market Analysis, 2025 (%)
• COMPETITIVE ANALYSIS
  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 6-3: Global POC Cardiac Markers Test Manufacturers, 2025 (%)

CHAPTER 7: POC SUBSTANCE ABUSE

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Urine
  • Oral
  • Blood-based
  • Hair
  • Nicotine and Alcohol
• MARKET SIZE AND GROWTH
  • Table 7-1: Global POC Drugs-of-Abuse Testing* Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 7-1: Global POC Drugs-of-Abuse Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 7-2: POC Substance Abuse Testing Regional Market Analysis, 2025 (%)
• POC Drugs of Abuse Self-Testing
  • Table 7-2: Global POC Drugs of Abuse Self-Testing Market, 2025-2030 (US$ millions, manufacturer level)
• POC Drugs of Abuse Professional Testing
  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 7-3: Global POC Drug of Abuse Testing Manufacturers, 2025 (%)

CHAPTER 8: POC PREGNANCY AND FERTILITY TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Table 8-1: Selected Pregnancy and Fertility CLIA-Waived Instruments, Devices, and Assays
• MARKET SIZE AND GROWTH
  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 8-1: Global POC Pregnancy and Fertility Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 8-2: POC Pregnancy and Fertility Testing Regional Market Analysis, 2025 (%)
• POC Pregnancy and Fertility Self-Testing
  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Pregnancy and Fertility Professional Testing
  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 8-3: Global POC Pregnancy and Fertility Testing Manufacturers, 2025 (%)

CHAPTER 9: POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Table 9-1: Selected POC and Home-Based Colon Cancer Screening Tests
• MARKET SIZE AND GROWTH
  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 9-1: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 9-2: POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2025 (%)
• POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Colon Cancer Screening/Fecal Occult Blood Professional Testing
  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 9-3: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers, 2025 (%)

CHAPTER 10: POC INFECTIOUS DISEASE TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
  • HIV and Hepatitis
  • Respiratory
  • STD/STI
  • Tropical Diseases
  • Lyme Disease
  • TB
  • Zika
  • Anthrax
  • Other Bacteria and Viruses
  • Hospital Acquired Infections and Sepsis
  • Sepsis
  • C. difficile
    • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
• MARKET SIZE AND GROWTH
  • Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 10-1: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 10-2: POC Infectious Disease (including COVID-19) Testing Regional Market Analysis, 2025 (%)
• POC Infectious Disease Self-Testing
  • Table 10-3: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Infectious Disease Professional Testing
  • Table 10-4: POC Infectious Disease Professional Testing (including COVID-19) Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Infectious Disease Testing by Disease Type
  • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2025 (US$ millions) [C. difficile, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Malaria, Respiratory, STD, Others]
• COMPETITIVE ANALYSIS
  • Table 10-6: Global POC Infectious Disease, including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 10-3: Global POC Infectious Disease Test Manufacturers, 2025 (%)

CHAPTER 11: POC LIPID TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
• MARKET SIZE AND GROWTH
  • Table 11-1: Global POC Lipid Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 11-1: Global POC Lipid Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 11-2: POC Lipid Testing Regional Market Analysis, 2025 (%)
• POC Lipid Self-Testing
  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Lipid Professional Testing
  • Table 11-3: POC Lipid Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 11-3: Global POC Lipid Testing Manufacturers, 2025 (%)

CHAPTER 12: POC CANCER TUMOR MARKER TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
• MARKET SIZE AND GROWTH
  • Table 12-2: Global POC Cancer Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 12-1: Global POC Cancer Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 12-2: POC Cancer Tumor Marker Testing Regional Market Analysis, 2025 (%)
• COMPETITIVE ANALYSIS
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 12-3: Global POC Cancer Testing Manufacturers, 2025 (%)

CHAPTER 13: POC URINE TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
• MARKET SIZE AND GROWTH
  • Table 13-1: Global POC Urine Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 13-1: Global POC Urine Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 13-2: POC Urine Testing Regional Market Analysis, 2025 (%)
• POC Urine Self-Testing
  • Table 13-2: POC Urine Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Urine Test Professional Testing
  • Table 13-3: POC Urine Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 13-3: Global POC Urine Strip Testing Manufacturers, 2025 (%)

CHAPTER 14: MISCELLANEOUS POC TESTING

• INTRODUCTION AND SCOPE
• MICROBIOLOGY
  • Table 14-1: Global POC Microbiology Test Sales, 2025-2030 (US$ millions)
• TSH
  • Table 14-2: Global POC Thyroid-Stimulating Hormone (TSH) Test Sales, 2025-2030 (US$ millions)
• ALLERGY
  • Table 14-3: Global POC Allergy Test Sales, 2025-2030 (US$ millions)
• AUTOIMMUNE
  • Table 14-4: Global POC Autoimmune Test Sales, 2025-2030 (US$ millions)
• OTHERS
  • Table 14-5: Global POC Other Test Sales, 2025-2030 (US$ millions)
• MISCELLANEOUS POC TESTING MARKET SIZE AND GROWTH
  • Table 14-6: Global Miscellaneous POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 14-1: Global Miscellaneous POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Table 14-7: Global POC Miscellaneous Sales, by Test Category, 2025-2030 (US$ millions) [Allergy, Autoimmune, Microbiology, TSH, Others]
• POC Miscellaneous Test Sales by Setting
  • Table 14-8: POC Miscellaneous Test Sales by Setting 2025-2030 ($millions)
  • Regional Analysis
  • Figure 14-2: POC Miscellaneous Testing Regional Market Analysis, 2025 (%)

CHAPTER 15: ISSUES AND TRENDS

• INTRODUCTION AND SCOPE
• TARIFFS AND THE POC INDUSTRY
• BREATH TEST ADVANCES
  • Table 15-1: Selected Disease Markers in Exhaled Breath
• MOBILE HEALTHCARE TECHNOLOGIES
• TELEHEALTH
• EARLY SEPSIS DETECTION
• PERSONALIZED MEDICINE
• REGULATORY HURDLES
• REIMBURSEMENT CHALLENGES
• PAMA
• POC AND MOLECULAR DIAGNOSTICS
  • Table 15-2: Selected Market Available Molecular POC Diagnostic Platforms
• CHINA AS A POC MARKET
• ADVANCING POC TECHNOLOGIES
• POC CONNECTIVITY
• MULTIPLEXED POC TESTING
• EMERGING NON-INVASIVE TECHNOLOGIES
  • Saliva and Swab
  • Optical Techniques
  • Volatolomics
  • POC AND ANTIMICROBIAL STEWARDSHIP
  • ARTIFICIAL INTELLIGENCE IN POC
  • HYBRID EMERGENCY DEPARTMENT /URGENT CARE CENTERS AND POC
  • DIGITAL DIAGNOSTICS
  • MICROFLUIDICS AND POC

CHAPTER 16: TOTAL GLOBAL POC TESTING MARKET AND COMPETITOR ANALYSIS

• MARKET OVERVIEW
  • Table 16-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
  • Figure 16-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
• MARKET ANALYSIS BY PRODUCT CATEGORIES
  • Table 16-2: Global POC Testing Market Analysis, by Product Category, 2025 (US$ millions) [Professional Testing, Self-Testing]
• MARKET ANALYSIS BY SUBCATEGORY
  • POC Self-Testing
    • Table 16-3: Global POC Self-Testing Market Analysis, by Product Category, 2025 (US$ millions) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
    • Figure 16-2: Global POC Self-Testing Market Analysis, by Product Category, 2025 (%) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
  • POC Professional Testing
    • Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2025 (US$ millions) [Blood & Electrolytes, Cardiac Markers, Cancer Tumor Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous]
    • Figure 16-3: Global POC Professional Testing Market Analysis, by Product Subcategory, 2025 (%) [Blood & Electrolytes, Cardiac Markers, Cancer Tumor Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous]
• MARKET ANALYSIS BY COUNTRY
  • United States
    • Table 16-5: US POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Europe
    • Table 16-6: Europe POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Germany
  • France
  • United Kingdom (UK)
  • Switzerland
  • Other (Russia)
    • Figure 16-4: European POC Testing Market Share, by Country, 2025 (%)
  • Japan
    • Table 16-7: Japan POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Rest of World
  • Latin America
  • China
  • India
  • South Korea
  • Vietnam and Other Southeast Asia
    • Table 16-8: Global POC Testing Market Analysis, by Rest of World Region/Country, 2025 (US$ millions) [Australia; China; India; Latin America, Middle East and Canada; South Korea and other Asian countries; Other]
    • Figure 16-5: Rest of World POC Testing Market Share, by Country, 2025 (%) [Australia, China, India, Latin America, South Korea, Other]
    • Table 16-9: Global POC Testing Analysis, by Region/Country, 2025 (US$ millions)
    • Figure 16-6: Global POC Testing Market Analysis, Market Share by Region/Country, 2025 (%)
• COMPETITIVE ANALYSIS
  • Table 16-10: Global Top POC Testing Market Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 16-7: Global POC Testing Market Share, by Leading Suppliers, 2025 (%)